ISTH 2015

Area: Internal Medicine

Location: Toronto, Canada

Date: June 20 to June 25


Search in Scientific Content:
Date
Filters:
Mathematic
7:40

Mathematic modelling of fibrinolysis

Presenter: Brittany Bannish
Internal Medicine
Pre and pe
2:02

Pre and perioperative factors modulate fibrinolysis in arthroplasty patients

Presenter: Drew Burleson
Internal Medicine
Cellular a
31:38

Cellular and mechanical modulators of fibrin structure

Presenter: Kraszimir Kolev
Internal Medicine
Platelets,
41:33

Platelets, NETs and Immunity

Presenter: Paul Kubes
Internal Medicine
Mechanisms
17:59

Mechanisms by which DNA, histones and NETs stabilise clots

Presenter: Imre Varju
Internal Medicine
Free fatty
3:31

Free fatty acids modulate thrombin activity ov fibrinogen and destabilise fibrin clots

Presenter: Anna Tanka-Salamon
Internal Medicine
Genetics o
31:21

Genetics of thrombosis

Presenter: David Ginsburg
Internal Medicine
Non-coding...
40:23

Non-coding RNAs – novel therapeutic targets in cardiovascular disease

Presenter: Stefanie Dimmeler
Internal Medicine
Antithromb
52:57

Antithrombotic therapy in cardiovascular patients

Presenter: Eugene Braunwald
Internal Medicine
Controvers
7:27

Controversies in the treatment of pulmonary embolism

Presenter: Alexander Gallus
Internal Medicine
Novel oral
17:24

Novel oral anticoagulants and anti F-XI agents

Presenter: Eduardo Ramacciotti
Internal Medicine
Antithromb
10:10

Antithrombotic therapy in cardiovascular patients

Presenter: Eugene Braunwald
Internal Medicine
Controvers
4:36

Controversies in the diagnosis of pulmonary embolism

Presenter: Gregoire Le Gal
Internal Medicine
Novelties
11:46

Novelties in the treatment of von Willebrand disease

Presenter: Margaret Ragni
Internal Medicine
NOACs in t
8:00

NOACs in the treatment of pulmonary embolism

Presenter: Menno Huisman
Internal Medicine
Impact of
3:36

Impact of incidental MI on future risk on venous thromboembolism (Tromso study)

Presenter: Ludvig B. Rinde
Internal Medicine
ISTH Congr
4:44

ISTH Congress

Presenter: Sam Schulman
Internal Medicine
Cancer-ass
9:20

Cancer-associated thrombosis and LMWH biosimilars

Presenter: Jawed Fareed
Internal Medicine
The RE-VER
7:19

The RE-VERSE AD trial: Idarucizumab reverses the anticoagulant effects of dabigatran

Presenter: Charles V. Pollack
Internal Medicine
Translatin
11:38

Translating the results of the NOAC trials into real-life setting

Presenter: Graham Turpie
Internal Medicine
Real-life
7:18

Real-life experience with the NOACs

Presenter: Harry Büller
Internal Medicine
The burden
13:20

The burden of thrombosis and the revolution in its treatment

Presenter: Jeffrey Weitz
Internal Medicine
Overview o
13:57

Overview of the use of NOACs

Presenter: John William Eikelboom
Internal Medicine
Opening ve
4:43

Opening vessels: From fibrinolysis to interventions

Presenter: Robert Medcalf
Internal Medicine
Perioperat
9:00

Perioperative Management of Dabigatran: A Prospective Cohort Study

Presenter: Sam Schulman
Internal Medicine

EULAR 2021

2021-06-02 - 2021-06-05
Online, Virtual

Written reports

2020-10-27 - 2020-10-28
Online, Virtual

PAINWeek 2020

2020-09-11 - 2020-09-13
Online, Virtual

EULAR 2020

2020-06-03 - 2020-06-06
Online, Virtual

EASD 2019

2019-09-16 - 2019-09-20
Barcelona, Spain

ESH 2019

2019-06-21 - 2019-06-24
Milan, Italy

EASD 2018

2018-10-01 - 2018-10-05
Berlin, Germany

ESH 2018

2018-06-08 - 2018-06-11
Barcelona, Spain

EAS 2018

2018-05-05 - 2018-05-08
Lisbon, Portugal